Your shopping cart is currently empty

Edonentan (BMS 207940) hydrate effectively blocks the endothelin A (ETA) receptor as a potent and selective antagonist, featuring a K i of 10 pM. It exhibits complete (100%) oral bioavailability in rats [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,820 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,380 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,100 | 10-14 weeks | 10-14 weeks |
| Description | Edonentan (BMS 207940) hydrate effectively blocks the endothelin A (ETA) receptor as a potent and selective antagonist, featuring a K i of 10 pM. It exhibits complete (100%) oral bioavailability in rats [1]. |
| Targets&IC50 | ETA:10 pM (Ki) |
| In vivo | Edonentan (3-10 µmol/kg, orally) can block significant ET-1 pressor responses [1]. Compared to BMS-193884, Edonentan (BMS 207940) exhibits improved systemic clearance (Cl) and volume of distribution at steady state (Vss) [1]. |
| Synonyms | BMS 207940 hydrate |
| Molecular Weight | 554.66 |
| Formula | C28H34N4O6S |
| Cas No. | 264609-13-4 |
| Smiles | C(N(C(CC(C)(C)C)=O)C)C1=C(C=CC(=C1)C2=NC=CO2)C3=C(S(NC=4C(C)=C(C)ON4)(=O)=O)C=CC=C3.O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.